Rankings
▼
Calendar
XERS Q3 2017 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena
XERS
Xeris Biopharma Holdings, Inc.
$982M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$170,000
Gross Profit
$170,000
100.0% margin
Operating Income
-$8M
-4454.1% margin
Net Income
-$8M
-4427.6% margin
EPS (Diluted)
$-3.72
QoQ Revenue Growth
-69.9%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$104,000
← FY 2017
All Quarters
Q4 2017 →
